MXPA03003785A - Suspension de una proteina epi-hne, proceso de preparacion de la misma, aerosol en polvo seco derivado de la misma, composiciones farmaceuticas conteniendo dicha suspension o aerosol y sus usos. - Google Patents

Suspension de una proteina epi-hne, proceso de preparacion de la misma, aerosol en polvo seco derivado de la misma, composiciones farmaceuticas conteniendo dicha suspension o aerosol y sus usos.

Info

Publication number
MXPA03003785A
MXPA03003785A MXPA03003785A MXPA03003785A MXPA03003785A MX PA03003785 A MXPA03003785 A MX PA03003785A MX PA03003785 A MXPA03003785 A MX PA03003785A MX PA03003785 A MXPA03003785 A MX PA03003785A MX PA03003785 A MXPA03003785 A MX PA03003785A
Authority
MX
Mexico
Prior art keywords
suspension
aerosol
dry powder
epi
preparation
Prior art date
Application number
MXPA03003785A
Other languages
English (en)
Inventor
Alain Poncin
Original Assignee
Debiopharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP00403035A external-priority patent/EP1201249A1/en
Application filed by Debiopharm Sa filed Critical Debiopharm Sa
Publication of MXPA03003785A publication Critical patent/MXPA03003785A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invencion concierne a una suspension de particulas cristalizadas de una proteina EPI-hNE, metodos para preparar dicha suspension, un aerosol de polvo seco derivado de dicha suspension, una formulacion farmaceutica inhalable comprendiendo dicha suspension o dicho aerosol de polvo seco, y el uso de dicha formulacion farmaceutica inhalable en el tratamiento de varias condiciones patologicas.
MXPA03003785A 2000-10-31 2001-10-26 Suspension de una proteina epi-hne, proceso de preparacion de la misma, aerosol en polvo seco derivado de la misma, composiciones farmaceuticas conteniendo dicha suspension o aerosol y sus usos. MXPA03003785A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00403035A EP1201249A1 (en) 2000-10-31 2000-10-31 Suspension of EPI-HNE-4, dry powder aerosol derived therefrom, process of preparation thereof, pharmaceutical compositions containing said suspension or aerosol, and their uses
EP01401731 2001-06-28
PCT/EP2001/012983 WO2002036158A1 (en) 2000-10-31 2001-10-26 Suspension of an epi-hne protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses

Publications (1)

Publication Number Publication Date
MXPA03003785A true MXPA03003785A (es) 2004-04-20

Family

ID=26073607

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03003785A MXPA03003785A (es) 2000-10-31 2001-10-26 Suspension de una proteina epi-hne, proceso de preparacion de la misma, aerosol en polvo seco derivado de la misma, composiciones farmaceuticas conteniendo dicha suspension o aerosol y sus usos.

Country Status (16)

Country Link
US (1) US6814982B2 (es)
EP (1) EP1223972B1 (es)
JP (1) JP2004512377A (es)
KR (1) KR100826342B1 (es)
CN (2) CN1287856C (es)
AT (1) ATE245445T1 (es)
AU (2) AU1701402A (es)
BR (1) BR0115020A (es)
CA (1) CA2426992A1 (es)
DE (1) DE60100500T2 (es)
DK (1) DK1223972T3 (es)
ES (1) ES2203601T3 (es)
HK (1) HK1048064B (es)
MX (1) MXPA03003785A (es)
PT (1) PT1223972E (es)
WO (1) WO2002036158A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
CA2488558C (en) 2002-06-07 2013-08-20 Dyax Corp. Prevention and reduction of blood loss
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
WO2005021557A2 (en) * 2003-08-29 2005-03-10 Dyax Corp. Poly-pegylated protease inhibitors
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
EP1830810A4 (en) * 2004-12-30 2011-02-02 Dobeel Co Ltd SPRAY-DRYED COMPOSITION WITH PROTEINS OF THE COLLECTIN FAMILY OR VARIATIONS THEREOF AND METHOD OF PREPARATION THEREOF
CA2696208A1 (en) * 2007-08-21 2009-02-26 Genzyme Corporation Treatment with kallikrein inhibitors
WO2010080833A1 (en) 2009-01-06 2010-07-15 Dyax Corp. Treatment of mucositis with kallikrein inhibitors
SI2521568T1 (sl) 2010-01-06 2019-01-31 Dyax Corp. Proteini, ki vežejo plazemski kalikrein
IL269565B2 (en) 2011-01-06 2024-06-01 Dyax Corp KALLIKREIN PLASMA BINDING PROTEINS
BR112016022318A2 (pt) 2014-03-27 2017-10-31 Dyax Corp método, composição farmacêutica para uso no tratamento de doenças de retina e uso de um anticorpo
JP7003354B2 (ja) 2015-12-11 2022-03-04 武田薬品工業株式会社 遺伝性血管性浮腫の発作を治療するための血漿カリクレイン阻害薬およびその用途
CN110141561A (zh) * 2018-03-29 2019-08-20 中国人民解放军军事科学院军事医学研究院 一种可气溶胶化蛋白干粉吸入剂的制备技术

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663143A (en) * 1988-09-02 1997-09-02 Dyax Corp. Engineered human-derived kunitz domains that inhibit human neutrophil elastase
US5148381A (en) * 1991-02-07 1992-09-15 Intel Corporation One-dimensional interpolation circuit and method based on modification of a parallel multiplier
ES2124203T3 (es) * 1991-03-01 2004-04-16 Dyax Corp. Inhibidores de la elastasa neutrofila humana y la catepsina g humana.
EP1184393A1 (en) 2000-09-04 2002-03-06 Debiopharm S.A. Process for the purification of EPI-HNE proteins

Also Published As

Publication number Publication date
CN1636595A (zh) 2005-07-13
DE60100500T2 (de) 2004-04-15
WO2002036158A8 (en) 2004-03-04
DK1223972T3 (da) 2003-11-03
CN1287856C (zh) 2006-12-06
ES2203601T3 (es) 2004-04-16
US6814982B2 (en) 2004-11-09
EP1223972A1 (en) 2002-07-24
KR100826342B1 (ko) 2008-05-02
HK1048064B (zh) 2004-02-13
HK1048064A1 (en) 2003-03-21
BR0115020A (pt) 2003-12-23
AU2002217014B2 (en) 2006-11-02
WO2002036158A1 (en) 2002-05-10
ATE245445T1 (de) 2003-08-15
DE60100500D1 (de) 2003-08-28
EP1223972B1 (en) 2003-07-23
CA2426992A1 (en) 2002-05-10
CN1471405A (zh) 2004-01-28
KR20030059809A (ko) 2003-07-10
AU1701402A (en) 2002-05-15
US20040013659A1 (en) 2004-01-22
JP2004512377A (ja) 2004-04-22
PT1223972E (pt) 2003-11-28
CN100396329C (zh) 2008-06-25

Similar Documents

Publication Publication Date Title
AU1701402A (en) Suspension of an epi-hne protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses
HUP0303398A3 (en) 1,2-dihydropyridine compounds, process for preparation of the same and use thereof and pharmaceutical compositions containing the same
HUP0101608A2 (hu) Aeroszol formájú gyógyszerkészítmény és eljárás előállítására
IL219397A0 (en) Compounds for the treatment of metabolic disorders, methods of preparing same, and pharmaceutical compositions containing same
HUP0200309A2 (en) Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression, process for their preparation and pharmaceutical compositions containing them
HUP0401537A3 (en) Thiohydantoins, process for their preparation, pharmaceutical compositions containing them and use thereof for preparation of pharmaceutical compositions
HUP0301046A3 (en) Quinazoline derivatives for the treatment of tumours, process for their preparation and pharmaceutical compositions containing them
HUP0204399A3 (en) Pteridine compounds for the treatment of psoriasis, process for their preparation, pharmaceutical compositions containing them and their use
HUP0204519A3 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, pharmaceutical compositions containing them and process for their preparations
AU5936400A (en) Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same
HUP0402264A3 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines process for preparing them, pharmaceutical compositions containing them and use thereof
WO2003099771A3 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
IL204947A0 (en) Phenylacetamido-thiazole derivatives, process for their preparation and their use in the manufacture of medicaments, pharmaceutical compositions and kits comprising them
HUP0301167A3 (en) Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders, process for their preparation, pharmaceutical compositions containing them and their use
CA2461517A1 (en) Nicotine formulations comprising cocoa and use thereof
HUP0401747A3 (en) Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds
HUP0202233A3 (en) Derivatives and analogues of galanthamin, their use, pharmaceutical compositions containing them and process for the preparation of them
AU7201298A (en) Dry powder inhaler excipient, process for its preparation and pharmaceutical compositions containing it
HUP0401325A3 (en) Isoxazolopyridinones useful in the treatment of parkinson's disease, process for their preparation and pharmaceutical compositions containing the compounds
IL141325A0 (en) Tan-1057 derivatives
HUP0301116A3 (en) Novel form of (r)-n-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide, process for its preparation and pharmaceutical composition containing it
AU2003259986A1 (en) Pharmaceutical compositions
HUP0303804A3 (en) Ligands of the avss6 integrin, process for their preparation, their use and pharmaceutical compositions containing them
HUP0400773A3 (en) 7-(4-tert-butylyclohexyl)-5-ethyl-3h-imidazo[5,1-f][1,2,4]triazin-4-on derivatives, their use pharmaceutical compositions containing them and process for the preparation of the compounds
UA66932C2 (en) Complex of eletriptan and sulphobutylether-beta-cyclodextrin, pharmaceutical composition, method for their manufacture and method for treating migraine

Legal Events

Date Code Title Description
FG Grant or registration